Press Releases May 4, 2026 09:08 AM

Forward Industries Schedules Fiscal Second Quarter 2026 Conference Call for May 14, 2026 at 5:00 p.m. ET

Forward Industries to Discuss Fiscal Q2 2026 Financials and SOL Treasury Strategy in Upcoming Earnings Call

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
FWDI

Forward Industries, a Nasdaq-listed company focused on Solana digital assets, announced a conference call scheduled for May 14, 2026, to review its fiscal second quarter financial and operational results along with updates on its Solana treasury strategy. The company aims to strengthen the Solana ecosystem through strategic investments, staking, and holding SOL assets.

Forward Industries Schedules Fiscal Second Quarter 2026 Conference Call for May 14, 2026 at 5:00 p.m. ET
FWDI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Forward Industries is hosting an earnings call to discuss Q2 2026 results and Solana (SOL) treasury strategy.
  • The company focuses on acquiring, staking, and investing in Solana assets and related projects to increase shareholder value.
  • Key strategic partners include industry leaders Galaxy Digital and Jump Crypto, supporting Forward's digital asset treasury approach.

AUSTIN, TX, May 04, 2026 (GLOBE NEWSWIRE) -- Forward Industries, Inc. (NASDAQ: FWDI) (the "Company" or “Forward”), the leading Solana treasury company, today announced that it will host a conference call on Thursday, May 14, 2026, at 5:00 p.m. Eastern Time to discuss its financial and operating results for the fiscal second quarter ended March 31, 2026, along with an update on its SOL treasury strategy. The Company plans to release its financial results in a press release prior to the call.

Forward Industries’ executive team will host the conference call and webcast presentation, followed by a question-and-answer period.

Conference Call and Webcast Details
Date: Thursday, May 14, 2026
Time: 5:00 p.m. ET
Webcast: FWDI's FQ2'26 Earnings Conference Call

Participants can also access the Company’s earnings call using the call in option here for instant telephone access to the event, which will be active approximately 15 minutes before the scheduled start time.

If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.

About Forward Industries, Inc.
Forward Industries, Inc. (NASDAQ: FWDI) is a Solana focused digital asset treasury company, with the strategy to buy, hold, stake, trade, invest in, and grow SOL and SOL related digital assets, protocols and businesses. Forward’s mission is to expand and strengthen the Solana ecosystem by acquiring and staking SOL and engaging with, providing tools to and investing in the Solana network, Solana developers and Solana related projects in order to increase shareholder value. In connection with a private placement transaction in September 2025, Forward launched a digital asset treasury strategy supported by industry leading investors and operating partners including Galaxy Digital and Jump Crypto. For more information on the Company's Solana treasury strategy, visit www.forwardindustries.com.

Contacts
Media Contact
Garrison Yang
Forward Industries, Inc.
comms@forwardindustries.com

Investor Relations Contact
Sean Mansouri, CFA / Aaron D’Souza
Elevate IR
(720) 330-2829
ir@forwardindustries.com


Risks

  • Market volatility and regulatory uncertainties associated with digital assets and cryptocurrency investments.
  • Dependence on the performance and adoption of the Solana blockchain ecosystem.
  • Potential technological or operational challenges in managing and growing SOL-related assets and projects.

More from Press Releases

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 Jun 14, 2026 Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026 Jun 14, 2026 Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control Jun 14, 2026 Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Jun 14, 2026